慢性心力衰竭患者血清25-(OH)D<sub>3</sub>、hsCRP及NT-proBNP水平与心力衰竭程度和预后的相关性

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (710 KB) RICH HTML
输出: BibTeX | EndNote (RIS)

摘要目的分析与探讨血清25-(OH)D₃、hsCRP及NT-proBNP在不同程度心力衰竭患者中的表达,并研究其与疾病预后的相关性及指导价值。方法选择2015-2017年检查确诊的108例慢性心力衰竭患者作为慢性心力衰竭组,随机选取108例体检健康者作为健康对照组。比较两组血清25-(OH)D₃、hsCRP、NT-proBNP检测值,观察不同心力衰竭程度及发生主要心血管不良事件(MACE,the major adverse cardiovascular events,包括心血管死亡、非致死性心肌梗死及卒中)时三种血清因子检测值变化。结果慢性心力衰竭组与对照组比较,血清25-(OH)D₃检测值明显下降,hsCRP、NT-proBNP检测值明显上升,差别存在统计学意义(P<0.05)。慢性心力衰竭组医治后25-(OH)D₃(20.85±4.87)μg/L、hsCRP(10.58±3.04)mg/L及NT-proBNP(926.17±267.11)pg/ml检测值均优于医治前25-(OH)D₃(14.56±4.33)μg/L、hsCRP(17.69±3.68)mg/L及NT-proBNP(1588.64±574.39)pg/ml检测值,差异有统计学意义(P<0.05)。随着心力衰竭严重程度加重,血清25-(OH)D₃检测值明显降低、血清hsCRP、NT-proBNP检测值明显增高,差异有统计学意义(P<0.05)。有MACE患者血清25-(OH)D₃(10.62±3.44)μg/L低于未发生组25-(OH)D₃(14.29±3.21)μg/L,同时血清中hsCRP(18.99±3.25)mg/L、NT-proBNP(1688.34±375.66)pg/ml高于未发生组hsCRP(15.76±1.34)mg/L、NT-proBNP(1320.48±262.77)pg/ml,差异有统计学意义(P<0.05)。结论慢性心力衰竭疾病发展过程中,血清25-(OH)D₃、hsCRP、NT-proBNP的表达水平高低,对心力衰竭严重程度的判断存在指导意义,且随着病情的控制,三项指标检测值均明显改善,提示与慢性心力衰竭的治疗转归及预后存在明显相关性。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王安惠

关键词 ： 25-(OH)D₃, 关系, hsCRP, 心力衰竭程度和预后, NT-proBNP

Abstract：Objective To analyze and explore the expressions of serum 25(OH)D₃, hsCRP and NT-proBNP in patients with different degrees of heart failure, and to study their correlations with and guidance for the prognosis of the disease.Methods One hundred and eight patients with chronic heart failure who had been diagnosed at our hospital between 2015 and 2017 were selected as the study group, while another 108 healthy subjects were randomly selected as the control group. Serum 25(OH)D₃, hsCRP and NT-proBNP values were compared between the two groups.The degree of heart failure and changes in three serum factor values in case of major adverse cardiovascular events (MACE, including cardiovascular death, nonfatal myocardial infarction and stroke) were observed.Results Compared with control group, the serum 25(OH)D₃ detection value decreased significantly, while the detection value of hsCRP and NT-proBNP increased significantly, and the difference was statistically significant (P<0.05). In the study group, 25(OH)D₃ was (20.85±4.87) ug/L, hsCRP (10.58±3.04)mg/L and NT-proBNP (926.17±267.11) pg/ml after treatment, compared to (14.56±4.33) μg/L, (17.69±3.68 )mg/L and (1588.64±574.39) pg/ml, so the difference was statistically significant (P<0.05). As the severity of heart failure increased, the detection value of serum 25(OH)D₃ decreased significantly, while those of serum hsCRP and NT-proBNPwere significantly increased, with statistical significance (P<0.05). Serum 25(OH)D₃ of patients with MACE was(10.62±3.44) μg/L, lower than (14.29±3.21) μg/L among those without MACE, but serum hsCRP of the former was(18.99±3.25 mg/L0, and NT-proBNP was(1688.34±375.66) pg/ml, compared to(15.76 ± 1.34) mg/L and (1320.48±262.77) pg/ml of the latter, and the difference was of statistical significance (P<0.05).Conclusions During the progression of chronic heart failure, the expression levels of serum 25(OH)D₃, hsCRP and NT-proBNP can help the diagnosis of the severity of heart failure. The three indicators can improve with more effective control of the disease.

Key words： 25-(OH)D₃ relationship hsCRP degree of heart failure and prognosis NT-proBNP

收稿日期: 2017-12-12

ZTFLH:

R541.6

作者简介: 王安惠,硕士,主治医师。

引用本文:

王安惠. 慢性心力衰竭患者血清25-(OH)D₃、hsCRP及NT-proBNP水平与心力衰竭程度和预后的相关性[J]. 武警医学, 2018, 29(4): 367-370. WANG Anhui. Correlations of serum 25- (OH)D₃, hsCRP and NT-proBNP levels with degree of heart failure and prognosis in patients with chronic heart failure. Med. J. Chin. Peop. Armed Poli. Forc., 2018, 29(4): 367-370.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2018/V29/I4/367

[1]	蔺雪峰,石爽,张丽琴.冠心病患者血清hs-CRP、NT-proBNP、ADMA检测及其临床意义[J].陕西医学杂志,2016,45(1):104-105.
[2]	Tripathi R,Wang D,Sullivan R,et al. Depressed corin levels Indicate early systolic dysfunction before Increases of atrial natriuretic peptide/B-type natriuretic peptide and heart failure development[J].Hypertension,2016,67(2):362-367.
[3]	魏淑岩.强心饮联合心脉隆注射液对慢性心力衰竭患者血浆BNP、NT-proBNP水平及心功能的影响[J].四川中医,2017,35(4):80-82.
[4]	刘斌.心脉隆注射液对慢性心力衰竭患者NT proBNP、LVEF、CA125的影响[J].中西医结合心脑血管病杂志,2015,13(13):1536-1538.
[5]	卢红艳,宁伟明,苏新养.血清CRP、Fib及NT-proBNP对慢性房颤并发早期心衰的诊断价[J].海南医学,2017,27(8):1271,1273.
[6]	Sanchis L,Andrea R,Falces C,et al.Prognosis of new-onset heart failure outpatients and collagen biomarkers[J].Eur J Clin Invest,2015,45(8):842-849.
[7]	于世平,谭露芬.不同剂量硝酸甘油治疗急性左心衰竭患者对血浆NT-proBNP的影响[J].广州医药,2017,48(2):43-45.
[8]	罗萍,韩建勤,王习韫,等.心衰患者血浆中NTproBNP、hsCRP及LVEF的水平探讨[J].宁夏医科大学学报,2015,37(6):711,713.
[9]	Mittal S,Aktas M K,Moss A J,et al.The impact of nonsustained ventricular tachycardia on reverse remodeling,heart failure,and treated ventricular tachyarrhythmias in MADIT-CRT[J].J Cardiovasc Electrophysiol,2014,25(10):1082-1087.
[10]	张存泰,严雯.食物补充叶酸、维生素、鱼油的再评价[A].第二十四届长城国际心脏病学会议学术研讨会论文集[C],2013:8-11.
[11]	李生浩,杜映荣,徐肇元,等.肺心病合并冠心病患者血清sST2、NT-proBNP水平变化及意义[J].山东医药,2016,56(46):68,70.
[12]	Santoro D,Pellicano V,Cernaro V,et al.Role of vitamin Din vascular complications and vascular access outcome in patients with chronic kidney disease[J].Curr Med Chem,2016,23(17):1698-1707.
[13]	高枫,韩肖肖,毕云,等.慢性心衰患者血清NT proBNP和cTnI联合检测及临床意义[J].陕西医学杂志,2017,46(3):325,327.
[14]	何巧,黄勇.左心衰竭患者血清MR-ProANP、NT-proBNP含量与泵血功能、心室重构的相关性研究[J].海南医学院学报,2017,23(2):201-204,208.